Literature DB >> 15734007

Fundus abnormalities in a patient with type I Gaucher's disease with 12-year follow-up.

Tsung-Jen Wang1, Muh-Shy Chen, Yung-Feng Shih, Wuh-Liang Hwu, Ming-Yang Lai.   

Abstract

PURPOSE: To report a case of type I Gaucher's disease with rare presentation of fundus abnormalities in long-term observation.
DESIGN: Observational case report.
METHODS: This 53-year-old Taiwanese woman suffered from type I Gaucher's disease for 12 years, with initial presentation of hepatoslpenomegaly in 1992.
RESULTS: At that time, poor vision with unusual macular change and peripheral retinal vessel leakage was also noted. She received a complete ophthalmic examination at the initial visit and again 12 years later in 2003. She was treated with imiglucerase injection during the last 4 years. However, her visual acuity was 10/200 in both eyes. The macular and peripheral retinal degenerative change progressed after 12 years.
CONCLUSIONS: Fundus changes associated with Gaucher's disease are uncommon. We should not neglect the possibility of retinal involvement and progression in these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734007     DOI: 10.1016/j.ajo.2004.07.053

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Glucosylceramide transfer from lysosomes--the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data.

Authors:  M Elleder
Journal:  J Inherit Metab Dis       Date:  2006-11-02       Impact factor: 4.982

2.  Functional retinal changes in Gaucher disease.

Authors:  Seid-Fatima Seidova; Konstantin Kotliar; Frauke Foerger; Matthias Klopfer; Ines Lanzl
Journal:  Doc Ophthalmol       Date:  2008-09-06       Impact factor: 2.379

3.  Defects in the retina of Niemann-pick type C 1 mutant mice.

Authors:  Xin Yan; Lucy Ma; Marina Hovakimyan; Jan Lukas; Andreas Wree; Marcus Frank; Rudolf Guthoff; Arndt Rolfs; Martin Witt; Jiankai Luo
Journal:  BMC Neurosci       Date:  2014-11-29       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.